Medigus Ltd ADR (MDGS) Stock

DelistedNasdaq: MDGSMedigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally.

1.73
Final close · Jun 18, 2024

MDGS is no longer traded. Medigus Ltd ADR was delisted from the Nasdaq in June 2024.

Prices on this page are historical; the last trade was June 18, 2024 at $1.73.

Medigus Ltd ADR stock price history

Split-adjusted closes, 2015–2024

MDGS final trading statistics

Final close
$1.73
Final trading day
Jun 18, 2024
Market cap at delisting
$3.28M
Shares outstanding
1.89M
Final 52-week range
$1.50 – $5.25
Avg. volume (final 3 mo.)
76,252
All-time high (split-adj.)
$2613.64 · Sep 2015
All-time low (split-adj.)
$1.52 · May 2024
Return since IPO
-99.9%
Beta
1.37
Book value / share
$18.67
Price / book
0.09
Final 52 wk
1.505.25

Medigus Ltd ADR earnings per share

Earnings per share

Medigus Ltd ADR revenue & net income

RevenueNet income

Medigus Ltd ADR annual financials

Medigus Ltd ADR revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2023$91.72M-$16.0M—
FY2022$91.86M-$10.2M—
FY2021$10.12M$4.0M—
FY2020$531.0K-$6.8M-$0.09
FY2019$273.0K-$14.2M-$2.08

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Medigus Ltd ADR

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Medigus Ltd ADR stock FAQ

What happened to Medigus Ltd ADR stock?

Medigus Ltd ADR stock was delisted from the Nasdaq. Its final close was $1.73 on June 18, 2024.

Is MDGS stock still trading?

No. MDGS was delisted from the Nasdaq in June 2024 and no longer trades on a U.S. exchange.

What was the last price of MDGS stock?

MDGS closed at $1.73 on its final trading day, June 18, 2024, for a market value of about $3.28M.

What were Medigus Ltd ADR's revenue and earnings in its last full fiscal year?

Medigus Ltd ADR reported revenue of $91.72M and net income of -$16.0M in fiscal 2023, its last full year as a public company.

When did Medigus Ltd ADR go public?

Medigus Ltd ADR stock began trading on August 5, 2015.

Medical Devices stocks to research

All Healthcare stocks →